Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
1661
-
1662
Expression of high-risk CRLs and co-expression CRGs in the GBM cuproptosis model.
Published 2025Subjects: -
1663
-
1664
Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase.
Published 2025Subjects: -
1665
-
1666
-
1667
-
1668
-
1669
Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase.
Published 2025Subjects: -
1670
-
1671
-
1672
-
1673
-
1674
-
1675
-
1676
The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells.
Published 2025“…<i>n</i> = 2–4 biological replicates per condition, with 15 individuals per replicate. Significance levels for Student <i>t</i> test are indicated for adjusted <i>p</i> values: *<i>p</i> < 0.05, ***<i>p</i> < 0.001, ***<i>p</i> < 0.0001. d: day(s), n.s.: non-significant. …”
-
1677
-
1678
-
1679
Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice.
Published 2025Subjects: -
1680